Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Nov 25;4(7):792-794.
doi: 10.1016/j.jacbts.2019.10.003. eCollection 2019 Nov.

Emerging Therapies for Dystrophic Cardiomyopathy

Daniel J Garry  1 , Tamas Alexy  1
Affiliations
Editorial

Emerging Therapies for Dystrophic Cardiomyopathy

Daniel J Garry et al. JACC Basic Transl Sci. .
No abstract available

Keywords: cardiomyopathy; diastolic dysfunction; dystrophin; recombinant adeno-associated virus vectors; ribonucleotide reductase.

PubMed Disclaimer

Figures

None
Graphical abstract
See this image and copyright information in PMC

Comment on

  • doi: 10.1016/j.jacbts.2019.06.006

References

    1. Mendell J.R., Lloyd-Puryear M. Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy. Muscle Nerve. 2013;48:21–26. - PubMed
    1. Kamdar F., Garry D.J. Dystrophin-deficient cardiomyopathy. J Am Coll Cardiol. 2016;67:2533–2546. - PubMed
    1. Emery A.E. The muscular dystrophies. Lancet. 2002;359:687–695. - PubMed
    1. Cox G.F., Kunkel L.M. Dystrophies and heart disease. Curr Opin Cardiol. 1997;12:329–343. - PubMed
    1. Rybakova I.N., Patel J.R., Ervasti J.M. The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin. J Cell Biol. 2000;150:1209–1214. - PMC - PubMed

Publication types

LinkOut - more resources